Search - tctmd.com

Displaying 61 - 80 of 1033

Sort: Relevancy | Date

Presentation ACC 2024

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Presenter: Gregg W Stone

April 07, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

L.A. McKeown

February 13, 2024

News Daily News

DAPT Works When Started Up to 3 Days After Mild Stroke, TIA

Todd Neale

January 04, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk

Yael L. Maxwell

November 30, 2023

News Conference News VIVA 2023

New Carotid Stent Systems Associated With Low Stroke Risk

L.A. McKeown

November 09, 2023

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

Presentation TCT 2023

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Presenter: Masaru Ishida

October 26, 2023

Presentation TCT 2023

TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

Presenter: Manasi Tannu

October 26, 2023

Presentation TCT 2023

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

Presenter: Mostafa Elbanna

October 26, 2023

Presentation TCT 2023

TCT 174: The Impact of Pre-Hospital Statin Therapy on Cardiovascular Events in STEMI Patients without a History of Revascularization: Insights from the TWINCRE Registry

Presenter: KEI INUTSUKA

October 26, 2023

Presentation TCT 2023

TCT 165: Aspirin-Free Prasugrel Monotherapy: Thirty Days Clinical Outcome after Percutaneous Coronary Intervention in Chronic Coronary Syndrome and Non-ST Segment Elevation Acute Coronary Syndrome

Presenter: Gaku Nakazawa

October 26, 2023

Presentation TCT 2023

TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

Presenter: Aakash Garg

October 25, 2023

Presentation TCT 2023

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

Presenter: Hyunki LEE

October 25, 2023

Advertisement

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

What’s Going to Be Hot at ACC 2024

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

DAPT Works When Started Up to 3 Days After Mild Stroke, TIA

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Top Coronary Artery Disease News of 2023

Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk

New Carotid Stent Systems Associated With Low Stroke Risk

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

TCTMD’s Top 10 Most Popular Stories for October 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

TCT 174: The Impact of Pre-Hospital Statin Therapy on Cardiovascular Events in STEMI Patients without a History of Revascularization: Insights from the TWINCRE Registry

TCT 165: Aspirin-Free Prasugrel Monotherapy: Thirty Days Clinical Outcome after Percutaneous Coronary Intervention in Chronic Coronary Syndrome and Non-ST Segment Elevation Acute Coronary Syndrome

TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content